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Abstract
Introduction:  The  use  of  diagnostic  auditory  brainstem  response  testing  under  sedation  is  cur-
rently the  ‘‘gold  standard’’  in  infants  and  young  children  who  are  not  developmentally  capable
of completing  the  test.
Objective:  The  aim  of  the  study  is  to  compare  a  propofol-ketamine  regimen  to  an  oral  chloral
hydrate  regimen  for  sedating  children  undergoing  auditory  brainstem  response  testing.
Methods:  Patients  between  4  months  and  6  years  who  required  sedation  for  auditory  brain-
stem response  testing  were  included  in  this  retrospective  study.  Drugs  doses,  adverse  effects,
sedation times,  and  the  effectiveness  of  the  sedative  regimens  were  reviewed.
Results:  73  patients  underwent  oral  chloral  hydrate  sedation,  while  117  received  propofol-
ketamine  sedation.  12%  of  the  patients  in  the  chloral  hydrate  group  failed  to  achieve  desired
sedation  level.  The  average  procedure,  recovery  and  total  nursing  times  were  significantly
lower in  the  propofol-ketamine  group.  Propofol-ketamine  group  experienced  higher  incidence
of transient  hypoxemia.
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Conclusion:  Both  sedation  regimens  can  be  successfully  used  for  sedating  children  undergoing
auditory brainstem  response  testing.  While  deep  sedation  using  propofol-ketamine  regimen
offers more  efficiency  than  moderate  sedation  using  chloral  hydrate,  it  does  carry  a  higher
incidence  of  transient  hypoxemia,  which  warrants  the  use  of  a  highly  skilled  team  trained  in
pediatric cardio-respiratory  monitoring  and  airway  management.
© 2017  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/).
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Comparac¸ão  entre  o  uso  de  hidrato  de  cloral  e  propofol-quetamina  como  formas  de
sedac¸ão  para  exames  de  potenciais  evocados  auditivos  de  tronco  encefálico
Resumo
Introduc¸ão:  O  uso  de  testes  diagnósticos  de  potencial  evocado  auditivo  de  tronco  encefálico
sob sedac¸ão  é  atualmente  o  padrão-ouro  em  lactentes  e  crianc¸as  pequenas  que  não  têm  desen-
volvimento  suficiente  para  realizar  o  exame.
Objetivo:  O  objetivo  do  estudo  foi  comparar  a  sedac¸ão  de  crianc¸as  submetidas  a  testes  de
potencial evocado  auditivo  de  tronco  encefálico  com  propofol-quetamina  e  com  hidrato  de
cloral por  via  oral.
Método:  Pacientes  entre  4  meses  e  6  anos  de  idade  que  necessitaram  de  sedac¸ão  para  a
realizac¸ão do  potencial  evocado  auditivo  de  tronco  encefálico  foram  incluídos  nesse  estudo
retrospectivo.  Foram  revisadas  as  doses  dos  medicamentos,  os  efeitos  adversos,  os  tempos  de
sedac¸ão e  a  eficácia  das  formas  de  sedac¸ão.
Resultados:  73  pacientes  foram  submetidos  à  sedac¸ão  oral  com  hidrato  de  cloral,  enquanto  117
receberam sedac¸ão  com  propofol-quetamina.  12%  dos  pacientes  do  grupo  hidrato  de  cloral  não
alcanc¸aram o  nível  desejado  de  sedac¸ão.  Os  tempos  médios  de  procedimento,  recuperac¸ão  e  o
tempo total  de  cuidados  de  enfermagem  foram  significativamente  menores  no  grupo  propofol-
quetamina,  entretanto  este  grupo  experimentou  maior  incidência  de  hipoxemia  transitória.
Conclusão:  Ambos  os  regimes  de  sedac¸ão  podem  ser  utilizados  com  sucesso  para  sedar  crianc¸as
para realizac¸ão  do  exame  de  potencial  evocado  de  tronco  encefálico.  Embora  a  sedac¸ão  pro-
funda com  propofol  e  quetamina  oferec¸a  mais  eficiência  do  que  a  sedac¸ão  moderada  com  hidrato
de cloral,  ela  apresenta  maior  incidência  de  hipoxemia  transitória,  o  que  requer  uma  equipe
altamente  qualificada,  treinada  em  monitoramento  cardiorrespiratório  pediátrico  e  manejo  de
vias aéreas.
©  2017  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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earing  loss  can  lead  to  significant  developmental  impair-
ent  and  speech  delay  in  infants  and  young  children,  which
ecessitates  early  identification  and  therapy.  An  Auditory
rainstem  Response  (ABR)  is  an  objective  method  of  test-
ng  the  auditory  pathway.1 It  has  been  used  as  a  valuable
creening  test  for  hearing  loss  in  infants  and  young  children
ue  to  their  age  and  development  skills.2 Although  ABR  test-
ng  is  not  painful,  pediatric  patients  often  require  sedation
o  obtain  accurate  results.  Sedating  pediatric  patients  for
BR  could  be  done  either  by  the  anesthesiologist  provid-
ng  general  anesthetic  or  under  moderate  to  deep  sedation
dministered  by  a  procedural  sedation  service  team.3Since  children  are  routinely  discharged  home  after  the
ntervention,  the  ideal  sedative  agent  would  have  a  rapid
nset  and  favorable  side  effect  profile  while  producing  a  suf-
cient  level  of  sedation  for  study  completion,  allow  rapid
i
g
a
tatient  recovery,  and  have  a  low  cost.3 Different  seda-
ive  agents  and  routes  of  administration  have  been  utilized
or  ABR  testing  such  as  oral  chloral  hydrate,  intranasal
exmedetomidine,  rectal  pentobarbital,  intravenous  propo-
ol  and  general  anesthesia.4 Chloral  hydrate  (CH)  was  one  of
he  most  widely  used  regimens.3--5 While  its  mechanism  of
ction  is  still  unknown,  it  is  believed  that  its  sedative  effect
s  mediated  by  the  Gamma  Aminobutyric  Acid-A  receptors
GABA).  Despite  the  widespread  use  of  CH,  serious  concerns
ave  been  raised  about  its  safety  profile.6 Additionally,  CH
as  been  in  short  supply  since  2013  after  manufacturing  was
iscontinued  in  the  United  States  due  to  limited  availability
nd  low  utilization  market.
Propofol  is  an  intravenous  sedative-hypnotic  agent  that
s  used  for  induction  and  maintenance  of  deep  sedation  and
eneral  anesthesia.7 Propofol  has  many  properties  including
 rapid  onset,  a  short  duration  of  action  with  rapid  recovery
ime  and  minimal  adverse  events,  which  makes  it  an  ideal
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performed  using  PK,  while  73  were  performed  using  CH.
Patients’  demographics  are  summarized  in  Table  1. The  PK
group’s  patients  were  older  than  the  CH  group’s  patients
(Table  1).  Patients  in  the  PK  group  had  a  lower  heart  rate  at
Table  1  Demographics  of  the  two  sedative  regimen.a
Chloral
hydrate
(n  =  73)
Propofol
(n  =  117)
p-ValueARTICLE
Comparison  between  chloral  hydrate  and  propofol-ketamine
agent  for  pediatric  sedation  in  the  outpatient  setting.  The
combination  of  propofol  and  ketamine  for  pediatric  sedation
had  been  reported  to  provide  optimal  hemodynamic  stability
and  reduced  adverse  effects  when  compared  to  propo-
fol  alone.8 Additionally,  the  combination  of  propofol  and
ketamine  had  been  shown  to  be  beneficial  in  other  medical
fields  because  of  allowing  lower  doses  of  propofol,  resulting
in  the  reduction  of  the  undesirable  adverse  effects.  Many
authors  reported  the  advantages  of  propofol-ketamine  com-
bination  in  terms  of  hemodynamic  profile  and  pain  control
in  cancer  patients  undergoing  painful  procedures.9 Emerging
data  support  the  safety  and  efficacy  of  using  propofol  out-
side  the  operating  room  for  pediatric  outpatient  procedures
and  interventions  by  qualified  physicians  trained  in  seda-
tion  and  advanced  airway  management.10--12 Additionally,
with  increasing  numbers  of  pediatric  patients  undergoing
diagnostic  ABR  coupled  with  the  relative  shortage  of  anes-
thesiologists  and  operating  room  availability,  other  pediatric
subspecialists,  such  as  pediatric  critical  care  physicians,
have  stepped  in  to  provide  pediatric  procedural  sedation.13
The  aim  of  this  study  is  to  compare  the  efficacy,  efficiency
and  safety  of  a  propofol  infusion  combined  with  ketamine  to
chloral  hydrate  as  a  sedative  regimen  for  children  undergo-
ing  ABR  testing.
Methods
The  institutional  review  board  of  our  institution  (Study
n◦ 1204008435R003)  approved  this  retrospective  study.  All
pediatric  patients  between  the  ages  of  4  months  to  6  years
old  undergoing  sedation  for  ABR  were  included.  Patients  less
than  5  kg,  patients  who  had  a  history  of  a  previous  failed
procedural  sedation  and  patients  with  cardiac  disease  were
excluded  from  the  analysis.  An  ABR  technician  performed  all
ABR  testing  for  children  at  our  Children’s  Hospital.  The  tech-
nicians’  team  members  remained  the  same  during  the  study
period.  The  study  was  designed  as  a  retrospective  review
where  patients  were  analyzed  based  on  sedative  regimen
used  to  complete  the  ABR  test.
History  and  physical  exam  were  performed  and  docu-
mented  according  to  the  American  Academy  of  Pediatrics
(AAP)  guidelines  for  sedation.14 Written  consent  was
obtained  from  the  parent  or  guardian  prior  to  the  procedure.
Sedation  in  the  PK  group  was  performed  by  a  sedation  team
that  consisted  of  a  pediatric  intensivist  and  a  sedation  nurse
with  a  pediatric  critical  care  background  who  monitored
the  patient  during  and  after  each  procedure  along  with  the
intensivist  in  all  the  cases.  CH  group  sedation  was  provided
by  the  ABR  team  that  consisted  of  a  pediatric  nurse  with
experience  in  administering  and  monitoring  patients  during
moderate  sedation.  Guidelines  for  both  sedation  regimens
have  been  laid  down  by  the  AAP  regarding  the  monitoring,
management  and  discharging  of  children  during  procedural
sedation.15 All  patients  were  either  classified  as  ASA-OS  I or  II
per  the  American  Society  of  Anesthesiologists-Physical  Sta-
tus  classification  system.  Patients  were  without  any  solids
or  formula  intake  for  at  least  6  h  and  2  h  for  clear  liquids
prior  to  the  procedure.  Patients  in  the  PK  group  had  an
intravenous  catheter  placed  by  the  sedation  team.  Physio-
logic  parameters  such  as  heart  rate,  respiratory  rate,  oxygen
saturation  and  respiratory  plethysmography  were  continu- PRESS
edation  regimens  3
usly  monitored.  Noninvasive  blood  pressure  were  measured
very  5  min  throughout  the  procedure  and  every  15  min  after
ts  completion  until  the  patient  was  fully  awake.
For  the  PK  group,  a  small  dose  of  intravenous  ketamine
0.5  mg/kg  for  patients  who  weigh  less  than  20  kg  and
.25  mg/kg  for  patient  who  weigh  more  than  20  kg)  was
dministered  followed  by  intravenous  propofol.  Propofol
as  administered  as  an  initial  bolus  of  1--2  mg/kg  followed
y  an  infusion  drip  of  83  mcg/kg/minute  until  the  end  of
he  procedure.  Additional  boluses  of  1  mg/kg  of  propofol
ere  given  as  needed  to  achieve  deep  sedation  level  (level
)  based  on  the  Ramsay  Sedation  Scale.  For  those  in  the
H  group,  sedation  started  with  30  mg/kg  of  oral  chlo-
al  hydrate  and  was  followed  by  small  subsequent  doses
20  mg/kg)  within  20  min  interval  to  maximum  dose  of  1  g
f  needed  to  achieve  a moderate  sedation  level.  If the  child
as  not  sedated  during  the  testing  despite  the  additional
oses  of  the  drug,  it  was  considered  a  failure  of  sedation.
Adverse  events  were  recorded  including  development  of
ransient  hypoxemia  (oxygen  saturation  of  less  than  90%  for
0  s),  hypotension  (drop  in  systolic  blood  pressure  below
xpected  age  or  dropping  by  20%  from  starting  systolic
lood  pressure),  apnea  requiring  bag-mask  ventilation  and
ailure  to  complete  the  procedure.  Serious  adverse  events
uch  endotracheal  intubation  and  cardiac  arrest  were  also
ecorded.  Procedure  time  (PT)  was  defined  as  the  time
etween  the  first  doses  of  sedation  until  the  ABR  was
ompleted.  Recovery  time  (RT)  was  defined  as  the  inter-
al  between  the  completions  of  the  procedure  until  the
atient’s  level  of  conscious  returned  to  baseline.  Nurse  time
NT)  was  defined  as  the  total  time  spent  by  the  sedation
urse  during  the  whole  process  starting  from  patient  arrival
o  the  sedation  suite  till  discharge  home.
tatistical  analysis
omparisons  between  the  PK  and  CH  groups  were  performed
sing  Wilcoxon  rank  sum  tests  for  continuous  variables  and
hi-square  tests  for  categorical  variables.  Because  of  the
ge  and  weight  differences  between  groups,  additional  anal-
ses  were  performed  to  compare  the  groups  while  adjusting
or  age  and  weight.
esults
etween  2009  and  2012,  a  total  of  117  ABR  procedures  wereAge  (years)  1.8  (1.0)  2.7  (2.1)  0.003
Weight  (kg)  11.3  (2.8)  13.1  (4.8)  0.02
Female  28  (38%)  49  (42%)  0.63
a Data presented as Mean (SD) or n (%).
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Table  2  Comparison  between  the  two  sedative  regimen  dosing  and  adverse  effects.a
Chloral  hydrate
(n =  73)
Propofol
(n  =  117)
p-Value
Propofol  total  dose  (mg/kg)  n/a  5.4  (1.9)  n/a
Chloral hydrate  dose  (mg/kg)  33.4  (7.7)  n/a  n/a
Heat rate  pre-sedation  131.4  (18.4)  126.3  (22.7)  0.12
Heart rate  after  procedure  was  completed  115.8  (17.2)  101.2  (15.4)  <0.0001
Hypoxemia 1  (1%)  12  (10%)  0.0183
Apnea 0  (0%)  1  (1%)  0.43
Oxygen supplementation  0  (0%)  10  (9%)  0.01
Desired level  of  sedation  achieved 64  (88%) 117  (100%) <0.0001
A second  dose  of  medication  given 10  (14%) n/a
a Data presented as Mean (SD) or n (%) as appropriate.
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sigure  1  Comparison  between  the  two  sedative  regimens’
imes (*  indicates  a  p-value  <  0.0001  between  the  two  groups).
rocedure  completion  compared  to  the  CH  group;  they  also
ad  a  significantly  higher  percentage  of  transient  hypoxemia
nd  a  higher  percentage  of  patients  receiving  supplemen-
al  oxygen;  however,  apnea  was  not  statistically  different
etween  the  groups  (Table  2).  No  serious  adverse  events
ccurred  in  either  group.  However,  9  patients  (12%)  in  the
H  group  failed  to  achieve  a  moderate  level  of  sedation
nd  10  patients  (14%)  needed  a  subsequent  dose  of  CH  to
aintain  the  sedation.  Patients  in  the  PK  group  had  a  sig-
ificantly  shorter  procedure  time,  recovery  time,  and  total
urse  time  (Fig.  1).  Adjusting  for  age  and  weight  did  not
ffect  the  group  comparisons  (p  <  0.0001  for  heart  rate  at
rocedure  completion,  procedure  time,  recovery  time,  and
otal  nurse  time;  p  =  0.0114  for  desaturation;  p  =  0.0021  for
eceiving  supplemental  oxygen;  p  =  0.27  for  apnea).
iscussion
he  use  of  ABR  under  some  form  of  sedation  is  currently  the
‘gold  standard’’  test  to  diagnose  hearing  loss  in  infants  and
hildren  who  are  not  developmentally  ready  or  unable  to
omplete  behavioral  audiometry.16,17 While  chloral  hydrate
as  widely  used  as  oral  sedative  hypnotic  drug;  issues  con-
erning  its  efficacy  and  safety  continue  to  arise.2 On  the
ther  hand,  combining  propofol  and  ketamine  has  been  eval-
ated  in  large  case  studies  and  found  to  be  safe  and  effective
hen  administered  by  skilled  personnel,  resulting  in  a  more
apid  recovery,  shorter  stay  and  smoother  emergence.18,19
h
c
gIn  our  study,  88%  of  children  in  the  CH  group  success-
ully  achieved  moderate  level  of  sedation  using  an  average
ose  of  33.4  mg/kg.  However,  14%  of  our  patients  required
ore  than  one  dose  of  CH  due  to  agitation  or  waking  up
uring  the  testing.  Our  data  is  similar  to  what  Valenzueal
t  al.5 reported  where  the  majority  of  pediatric  patients
ere  successfully  sedated  using  oral  CH.  Avolnitou  et  al.  also
oncluded  that  the  vast  majority  of  children  were  sedated
uccessfully,  while  50%  of  them  required  a  second  dose  of
H  to  induce  the  sedation.  Around  12%  of  children  in  the
H  group  had  failed  to  reach  the  desired  level  of  moder-
te  sedation.  All  children  in  the  PK  group  were  successfully
edated,  which  is  consistent  with  the  study  performed  by
kin  et  al.3
In  terms  of  time  efficacy,  the  mean  procedure  time,
ecovery  time  and  total  nurse  time  were  significantly  lower
n  the  PK  group  compared  to  the  CH  group.  The  procedure
ime  in  the  CH  group  is  consistent  with  Avlonitou  et  al.2 find-
ngs  where  the  average  time  for  the  procedure  was  about
0  min.  The  most  likely  explanation  of  our  findings  in  terms
f  time  efficacy  is  the  extremely  rapid  onset  and  short  dura-
ion  of  action  of  propofol.20,21
In  terms  of  adverse  events,  patients  in  the  PK  group  had  a
0%  incidence  of  transient  hypoxemia  corrected  with  regu-
ar  nasal  cannula  compared  to  only  1%  in  the  CH  group.  Akin
t  al.  reported  that  transient  hypoxemia  occurred  in  11%
f  pediatric  patients  who  received  propofol  for  ABR  test-
ng.  The  Pediatric  Sedation  Research  Consortium  reported  a
ypoxia  rate  around  5%  for  procedural  sedation  when  propo-
ol  was  used.15 It  is  possible  to  explain  this  partially  due  to
he  longer  duration  and  less  stimulation  during  an  ABR  test
ompared  to  other  short,  more  painful  procedures,  such  as
 spinal  tap  or  a  bone  marrow  aspiration.
To  our  knowledge,  this  is  the  first  study  that  com-
ares  using  oral  chloral  hydrate  to  intravenous  propofol  and
etamine  for  sedation  for  ABR.  Our  study  shows  that  pro-
edural  deep  sedation  using  a  combination  of  propofol  and
etamine  for  ABR  testing  is  a  more  efficient  regimen  than
oderate  sedation  using  chloral  hydrate  with  respect  to  pro-
edure  time,  recovery  time  and  total  nursing  time.  Deep
edation  approach  using  propofol  and  ketamine  carried  a
igher  incidence  of  transient  hypoxemia  compared  to  the
hloral  hydrate  approach.
Our  study  has  a number  of  limitations;  first,  this  is  a  sin-
le  center  retrospective  non-randomized  study.  Second,  it
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compares  two  different  sedation  approaches  performed  by
two  different  teams  where  there  are  a  number  of  variables
that  are  impossible  to  control.  The  dose  of  chloral  hydrate
was  used  to  achieve  only  moderate  sedation  in  our  study
and  could  be  the  reason  for  having  a  higher  failure  rate  and
lower  adverse  events.
Conclusion
This  study  demonstrates  that  both  intravenous  propofol-
ketamine  and  oral  chloral  hydrate  are  effective  methods  of
sedating  children  undergoing  ABR  testing  in  the  outpatient
setting.  However,  deep  sedation  approach  using  propofol-
ketamine  is  superior  in  terms  of  efficiency  and  offers  some
workflow  advantages  over  moderate  sedation  using  chloral
hydrate.  Given  the  higher  incidence  of  transient  hypoxemia
compared  to  chloral  hydrate,  the  use  of  this  sedation  strat-
egy  should  be  restricted  to  practitioners  highly  trained  in  the
management  of  the  pediatric  airway  and  cardiorespiratory
monitoring.
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